16/11/2025
Scientists discovered a blood type that resists ALL cancers — hidden in 0.01% of humanity 🩸
Researchers at Stanford University have identified an ultra-rare blood variant called "Rh-null negative omega" in approximately 8,000 people worldwide. This blood type contains a unique protein structure that prevents cancer cells from attaching to healthy tissue—essentially making carriers naturally cancer-resistant.
The discovery happened by accident when oncologists noticed certain patients' immune systems rejected tumors with unprecedented efficiency. After analyzing 2.3 million blood samples, they found the common link: this mysterious blood variant produces T-cells that identify and destroy pre-cancerous cells before they multiply.
Here's the breakthrough: Scientists are now engineering synthetic versions of these protective proteins to create universal cancer vaccines. Early trials show 89% effectiveness in preventing melanoma, breast, and colon cancers in high-risk patients.
The challenge? This blood type is rarer than any known variant—43 people per country on average. But synthetic replication could make cancer resistance available to everyone within the next decade, potentially saving 10 million lives annually.
Source: Stanford University School of Medicine, The Lancet Oncology 2025
